AI and surgeons team up to improve breast reconstruction consultations

NCT ID NCT06981208

Recruiting now Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether using ChatGPT to create personalized educational materials helps patients better understand their breast reconstruction options before surgery. Participants scheduled for a breast reconstruction consultation are randomly assigned to receive either ChatGPT-generated education or the usual information from their surgeon. After their consultation, both patients and surgeons fill out surveys to measure understanding, satisfaction, and the usefulness of the AI-generated materials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ChatGPT-generated patient education
What this could lead to: If it works, this could point toward a more effective way to prepare patients for breast reconstruction consultations, improving understanding and satisfaction.
What could go wrong: This is a small, early-stage study focused on patient perception, not clinical outcomes. The ChatGPT materials may not improve understanding or satisfaction over standard education.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER CANCER OF THE BREAST

Contacts and locations

Locations

Washington University School of Medicine
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.